A detailed history of Kbc Group Nv transactions in Viatris Inc stock. As of the latest transaction made, Kbc Group Nv holds 1,040,708 shares of VTRS stock, worth $13 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,040,708
Previous 1,912,124 45.57%
Holding current value
$13 Million
Previous $20.3 Million 40.55%
% of portfolio
0.04%
Previous 0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$10.32 - $12.13 $8.99 Million - $10.6 Million
-871,416 Reduced 45.57%
1,040,708 $12.1 Million
Q2 2024

Jul 17, 2024

BUY
$10.05 - $12.02 $4.02 Million - $4.81 Million
400,478 Added 26.49%
1,912,124 $20.3 Million
Q1 2024

May 08, 2024

BUY
$11.27 - $13.53 $13.3 Million - $16 Million
1,179,639 Added 355.31%
1,511,646 $18 Million
Q4 2023

Feb 13, 2024

SELL
$8.77 - $10.85 $1.79 Million - $2.22 Million
-204,197 Reduced 38.08%
332,007 $3.6 Million
Q3 2023

Feb 15, 2024

SELL
$9.59 - $11.35 $2.2 Million - $2.61 Million
-229,788 Reduced 40.8%
333,375 $3.29 Million
Q2 2023

Feb 15, 2024

BUY
$9.02 - $10.29 $2.96 Million - $3.38 Million
328,209 Added 139.69%
563,163 $5.62 Million
Q2 2023

Jul 28, 2023

BUY
$9.02 - $10.29 $1.84 Million - $2.1 Million
204,452 Added 61.63%
536,204 $5.35 Million
Q1 2023

Feb 14, 2024

BUY
$9.2 - $12.26 $490,304 - $653,384
53,294 Added 18.78%
337,145 $3.24 Million
Q1 2023

May 04, 2023

BUY
$9.2 - $12.26 $907,027 - $1.21 Million
98,590 Added 42.28%
331,752 $3.19 Million
Q4 2022

Feb 14, 2024

BUY
$8.72 - $11.56 $944,768 - $1.25 Million
108,345 Added 61.73%
283,851 $3.16 Million
Q3 2022

Feb 15, 2024

SELL
$8.48 - $11.13 $823,009 - $1.08 Million
-97,053 Reduced 29.23%
234,954 $2 Million
Q3 2022

Nov 08, 2022

BUY
$8.48 - $11.13 $508,800 - $667,800
60,000 Added 34.65%
233,162 $1.99 Million
Q2 2022

Feb 14, 2024

BUY
$9.95 - $12.27 $23,322 - $28,760
2,344 Added 1.35%
175,506 $1.84 Million
Q4 2021

Feb 14, 2024

SELL
$12.09 - $14.68 $1.92 Million - $2.33 Million
-158,845 Reduced 47.84%
173,162 $2.34 Million
Q4 2021

Feb 03, 2022

SELL
$12.09 - $14.68 $1.35 Million - $1.64 Million
-111,920 Reduced 39.26%
173,162 $2.34 Million
Q3 2021

Nov 10, 2021

SELL
$13.25 - $15.13 $16,642 - $19,003
-1,256 Reduced 0.44%
285,082 $3.86 Million
Q2 2021

Aug 11, 2021

BUY
$12.97 - $16.15 $167,403 - $208,448
12,907 Added 4.72%
286,338 $4.09 Million
Q1 2021

Apr 26, 2021

BUY
$13.59 - $18.54 $150,278 - $205,015
11,058 Added 4.21%
273,431 $3.82 Million
Q4 2020

Feb 10, 2021

BUY
$14.3 - $18.74 $3.75 Million - $4.92 Million
262,373 New
262,373 $4.92 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.